The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.00
Bid: 32.50
Ask: 33.50
Change: 0.00 (0.00%)
Spread: 1.00 (3.077%)
Open: 33.00
High: 33.00
Low: 33.00
Prev. Close: 33.00
DUKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Follow-On Investment into Existing Royalty Partner

13 Dec 2022 07:00

RNS Number : 4463J
Duke Royalty Limited
13 December 2022
 

13 December 2022

 

Duke Royalty Limited

 

("Duke Royalty" or "Duke")

 

Follow-On Investment into Existing Royalty Partner

Duke Royalty, a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and North America, is pleased to announce a follow-on investment of £3.2 million into existing royalty partner Tristone Healthcare Limited ("Tristone") to fund its latest acquisition.

Tristone provides specialist residential and domiciliary care in two end markets: i) high acuity adults with severe mental, physical or learning disabilities; and ii) care leavers, aged between 16 and 19, who are transitioning out of social care and into independent living.

Highlights:

 

· Duke's funds will facilitate Tristone's acquisition of K Bond Healthcare Limited, trading as Next Steps ("Next Steps"), a well-respected residential and nursing care provider with operations across Greater Manchester

· The financing increases Duke's total investment into Tristone to £17.6 million. The investment terms are the same as Duke's previous follow-on investment into Tristone, including a starting yield of 13.5% and a +/- 6% annual revenue adjustment factor in respect of royalty payments due

· Next Steps represents Tristone's third acquisition supported by Duke, in line with Tristone's stated buy & build strategy

 

Neil Johnson, CEO of Duke Royalty, said:

"It is great to be supporting Tristone's acquisition of another successful company with this follow-on funding. Next Steps provides the highest quality of care and maintains a culture that aligns well with Tristone's own core set of beliefs. This acquisition represents an important strategic step in expanding Tristone's geographical presence in the North West and there is scope to open further facilities, replicating Next Steps' existing and highly successful model.

"Our flexible financing model is perfect for companies such as Tristone which are executing an effective buy and build strategy and our shareholders benefit from the growth that we achieve through expanding our relationship with a trusted partner."

Further information regarding Next Steps

Next Steps, which was founded in 2015, specialises in providing individuals with chronic and treatment-resistant mental illnesses with a therapeutic home environment to receive the highest quality of residential and nursing care. Employing 42 staff, and supporting 22 individuals, the provider currently operates across four specialist nursing homes. The care package for each service user is assessed on an individual basis, with Next Steps being a premium provider for complex cases at the higher end of the sector typical metrics.

Duke Royalty Portfolio

A full list of Duke's current Royalty Partners are now included for reference on the Partners page of our website: www.dukeroyalty.com/partners

 

 

***ENDS***

 

 

For further information, please visit www.dukeroyalty.com or contact:

 

Duke Royalty Limited

Neil Johnson / Charles Cannon Brookes / Hugo Evans

 

+44 (0) 1481 730 613

Cenkos Securities plc 

(Nominated Adviser

and Joint Broker)

Stephen Keys / Callum Davidson / Michael Johnson

+44 (0) 207 397 8900

Canaccord Genuity

(Joint Broker)

 

Adam James / Harry Rees

+44 (0) 207 523 8000

SEC Newgate (PR)

Elisabeth Cowell / Axaule Shukanayeva

+44 (0) 20 3757 6880 dukeroyalty@secnewgate.co.uk

 

About Duke Royalty

 

Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCTTBRTMTABBTT
Date   Source Headline
20th Apr 20215:19 pmRNSHolding(s) in Company
20th Apr 20214:19 pmRNSHolding(s) in Company
19th Apr 202112:30 pmRNSDirector / PCA Dealings
19th Apr 20217:00 amRNSSuccessful Exit of Investment in Royalty Partner
16th Apr 20213:14 pmRNSResult of General Meeting and Issue of Equity
6th Apr 20215:17 pmRNSResult of PrimaryBid Offer and Total Voting Rights
1st Apr 20217:00 amRNSResult of Placing
31st Mar 20214:32 pmRNSPrimaryBid Offer
31st Mar 20214:30 pmRNSPlacing to raise a minimum of £30 million
31st Mar 20214:30 pmRNSExit of Investment into Royalty Partner
18th Mar 20217:00 amRNSIncreased Interim Dividend & Dividend Declaration
15th Mar 20217:00 amRNSIncreased £35 Million Revolving Credit Facility
12th Mar 20217:00 amRNSHolding(s) in Company
10th Mar 20217:00 amRNSHolding(s) in Company
1st Mar 20212:05 pmRNSSecond Price Monitoring Extn
1st Mar 20212:00 pmRNSPrice Monitoring Extension
1st Mar 20217:00 amRNSFollow-on investment into existing royalty partner
19th Feb 20217:00 amRNSHolding(s) in Company
16th Feb 20217:00 amRNSNew Royalty Partner
9th Feb 20212:36 pmRNSHolding(s) in Company
4th Feb 20217:00 amRNSTrading Update
22nd Jan 202111:44 amRNSHolding(s) in Company
14th Jan 20217:00 amRNSFollow-on investment into existing Royalty Partner
11th Jan 20217:00 amRNSAppointment of Chief Investment Officer
24th Dec 20207:00 amRNSFollow-on investment into existing royalty partner
22nd Dec 20207:01 amRNSFollow-on investment into existing royalty partner
22nd Dec 20207:00 amRNSExit of Investment in Royalty Partner
9th Dec 20207:01 amRNSInterim Results
9th Dec 20207:00 amRNSReinstated Cash Dividend and Dividend Declaration
18th Nov 20207:01 amRNSInvestor Presentation
18th Nov 20207:00 amRNSNotice of Interim Results
12th Nov 20209:05 amRNSSecond Price Monitoring Extn
12th Nov 20209:00 amRNSPrice Monitoring Extension
12th Nov 20207:00 amRNSTrading Update and Reinstatement of Cash Dividend
21st Oct 20202:34 pmRNSResult of Annual General Meeting
21st Oct 20207:00 amRNSAppointment of Joint Broker
15th Oct 20205:35 pmRNSHolding(s) in Company
14th Oct 20201:00 pmRNSDirector/PDMR Dealings
2nd Oct 20203:47 pmRNSIssue of Equity for Scrip Dividend
2nd Oct 202012:39 pmRNSLTIP, Issue of Equity, Director/PDMR Holdings
1st Oct 20201:25 pmRNSScrip Dividend Reference Price
25th Sep 20207:00 amRNSPosting of Report and Accounts and Notice of AGM
17th Sep 20207:01 amRNSFinancial 2020 Final Results
17th Sep 20207:00 amRNSDividend Declaration
16th Sep 20207:00 amRNSTrading Update
14th Sep 20207:00 amRNSSuccessful Exit of Investment in Royalty Partner
10th Aug 20207:00 amRNSHolding(s) in Company
10th Aug 20207:00 amRNSFollow-on investment into existing royalty partner
6th Aug 20207:00 amRNSTrading Update and Notice of FY 2020 Results
5th Aug 20205:43 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.